Pathophysiology and Mechanisms
- Insulin Resistance and Impaired Glucose Metabolism
- Beta-Cell Dysfunction in Diabetes Pathophysiology
- Hormonal Imbalances in Endocrine Disorders
- Genetic and Epigenetic Mechanisms
- Inflammation and Immune Mechanisms
- Endocrine Disruptors and their Impact on Metabolism
- Role of Gut Microbiome in Endocrine and Metabolic Disorders
Diabetes is a chronic metabolic disorder characterized by impaired glucose metabolism resulting from defects in insulin secretion, insulin action, or both. It is primarily categorized into type 1 diabetes (T1D), type 2 diabetes (T2D), and gestational diabetes, with other rarer forms stemming from genetic or secondary causes. In T1D, an autoimmune process targets pancreatic beta cells, leading to their destruction and an absolute insulin deficiency. This destruction is mediated by T lymphocytes, which recognize beta-cell antigens as foreign, triggering inflammatory responses and cell apoptosis. Without insulin, glucose uptake by cells in muscles, liver, and adipose tissues is diminished, causing hyperglycemia. The persistence of high blood sugar levels leads to glucotoxicity, further impairing residual beta-cell function and exacerbating disease progression.
In T2D, the predominant mechanisms involve insulin resistance and relative insulin insufficiency. Insulin resistance, often driven by obesity and physical inactivity, disrupts glucose uptake in peripheral tissues, increasing blood sugar levels. Compensatory hyperinsulinemia initially maintains normoglycemia, but chronic beta-cell stress results in their dysfunction and failure. Adipose tissue dysfunction plays a critical role by secreting pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6), which exacerbate systemic inflammation and worsen insulin resistance. In parallel, lipotoxicity from excess free fatty acids directly damages pancreatic beta cells. Furthermore, gut-derived hormones like glucagon-like peptide-1 (GLP-1) exhibit diminished efficacy in T2D, impairing glucose-dependent insulin secretion. Over time, the combined effects of oxidative stress, inflammation, and metabolic derangements culminate in chronic complications, including macrovascular (e.g., cardiovascular disease) and microvascular (e.g., retinopathy, nephropathy) complications, making diabetes a major public health challenge.
